New management strategies in ARDS: Immunomodulation

Critical Care Clinics

Volumn 18, Issue 1, 2002, Pages 69-78

  Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; ACETYLCYSTEINE; ACTIVATED PROTEIN C; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; DAZOXIBEN; DROTRECOGIN; FLUOROCARBON; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 1; INTERLEUKIN 8; KETOCONAZOLE; LUNG SURFACTANT; METHYLPREDNISOLONE; NITRIC OXIDE; PENTOXIFYLLINE; PROSTACYCLIN; PROSTAGLANDIN E1; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ARACHIDONIC ACID METABOLISM; DRUG EFFICACY; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LIQUID VENTILATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW;

EID: 0036118326     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(03)00065-4     Document Type: Review

References (50)

1. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome (ARDS): A controlled, randomized, double-blind, multicenter clinical trial
2. 2 and reduces the period of ventilation in artifically ventilated patients
3. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome
4. A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill
5. Dopamine stimulates sodium transport and liquid clearance in rat lung epithelium
6. Liquid ventilation in ARDS
7. Beta-2-adrenoceptor agonists as inhibitors of lung vascular permeability to radiolabelled transferrin in the adult respiratory distress syndrome in man
8. High-dose corticosteroids in patients with the adult respiratory distress syndrome
9. Efficacy and safety of recombinant human activated protein C for severe sepsis
10. A trial of antioxidants N-acetylcysteine and procysteine in ARDS
11. The effects of ibuprofen on the physiology and survival of patients with sepsis
12. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome
13. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: Results of a multicenter, prospective, randomized, clinical trial
14. Current clinical options for the treatment and management of acute respiratory distress syndrome
15. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial
16. Treatment with N-acetylcysteine during acute respiratory distress syndrome: A randomized, double blind, placebo-controlled clinical study
17. Is outcome from ARDS related to the severity of respiratory failure?
18. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome
19. An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients
20. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis
21. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome
22. Bovine surfactant therapy for patients with acute respiratory distress syndrome
23. Partial liquid ventilation in adult patients with ARDS: A multicenter phase I-II trial
24. Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome
25. Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial
26. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma
27. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo-controlled study
28. Inhaled nitric oxide in acute respiratory distress syndrome
29. A randomized trial of isonitrogenous enteral diets after severe trauma: An immune-enhancing diet reduces septic complications
30. Administration of dazoxiben, a selective thromboxane synthetase inhibitor in patients with adult respiratory distress syndrome
31. Inhalation of nitric oxide in acute lung injury: Results of a European multicentre study
32. Effect of prolonged methylprednisolone therapy in unresolving respiratory distress syndrome: A randomized controlled trial
33. Effects of an immune-enhancing diet in critically injured patients
34. Pilot study of cardiopulmonary risk from pentoxifylline in adult respiratory distress syndrome
35. The use of inhaled nitric oxide as adjuvant therapy in patients with burn injuries and respiratory failure
36. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial
37. Dazoxiben in human sepsis and adult respiratory distress syndrome
38. Inhaled nitric oxide for the adult respiratory distress syndrome
39. Randomized trial of immune-enhancing enteral nutrition in burn patients
40. Modulation of lung liquid clearance by isoproterenol in rat lungs
41. Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: A randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions
42. Ketoconazole prevents acute respiratory failure in critically ill surgical patients
43. Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults
44. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study
45. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: A randomized controlled trial
46. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
47. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages
48. Ketoconazole inhibits alveolar macrophage production of inflammatory mediators involved in acute lung injury (adult respiratory distress syndrome)
49. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome
50. The effects of alpha and beta adrenergic stimulation on hepatosplanchnic perfusion and oxygen extraction in endotoxic shock